Idexx Laboratories reported $3.71B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Abbott USD 108.25B 968M Sep/2026
Accuray USD 448.01M 8.81M Dec/2025
Align Technology USD 6.52B 103.03M Sep/2026
AngioDynamics USD 269.68M 4.04M Sep/2025
Dentsply International USD 5.19B 14M Sep/2026
Dexcom USD 6.24B 216.5M Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Fujifilm JPY 6.1T 64.55B Sep/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Henry Schein USD 11.51B 129M Sep/2026
Idexx Laboratories USD 3.71B 264.77M Sep/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.42B 250M Sep/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
Neogen USD 3.3B 42.8M Jun/2026
Orthofix International USD 855.76M 17.26M Sep/2026
Phibro Animal Health USD 1.51B 13.48M Sep/2026
ResMed USD 8.21B 754.14M Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Steris USD 10.71B 22.5M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Zoetis USD 15.09B 11M Sep/2026